The newly established rat strain TGR(mREN2)27 is a monogenetic model in hypertension research. Microinjecting the mouse Ren-2d renin gene caused it to become a stable part of the genome. The rats are characterized by fulminant hypertension, low plasma active renin, suppressed kidney renin, high plasma inactive renin, and high extrarenal transgene expression, most prominently in the adrenal cortex. Additionally, they exhibit significantly enhanced excretion of corticosteroids.
Introduction
The endocrine renin-angiotensin system (RAS)' is a major focus in hypertension research. Its effector peptide angiotensin Dawley; TES, N-tris(hydroxymethyl)methyl-2-aminoethane-sulfonic acid.
II (ANGII) is a potent regulator of blood pressure and electrolyte balance. The aspartyl protease renin cleaves angiotensinogen to form the decapeptide ANGI. ANGI is further hydrolized to ANGII by angiotensin-converting enzyme.
The juxtaglomerular cells of the kidney are the major source of plasma active renin. A low sodium concentration in the proximal tubulus, low renal arterial pressure, noradrenaline, and the sympathetic nerve activity are important stimulators of kidney renin secretion. ANGII, high renal arterial pressure and calcium influx, however, are known inhibitors of renal renin release (for review see [1] ). The dynamic interactions ofblood pressure and electrolyte homeostasis with kidney renin are thus strongly involved in many forms of hypertension.
Growing evidence for renin synthesis and for the local generation of ANGII in many extrarenal tissues (1) (2) (3) (4) (5) has recently focused attention on the existence of autocrine or paracrine RAS and their possible importance in primary hypertension.
However, the function, regulations, and interactions between the plasma RAS and local paracrine RAS are far from being understood.
The existence of an adrenal RAS had already been proposed in 1967 by Ryan (6) and Ganten et al. (2, 7) , who demonstrated the presence of iso-renin in rat and human adrenal gland and its stimulation by long-term sodium deficiency and hypophysectomy. The description of modified smooth muscle cells in the adrenal capsule with a similarity to kidney juxtaglomerular cells by Goormaghtigh and Handovsky (8), and the demonstration ofrenin secretory granules by Mizuno et al. (9) , suggest the possibility of regulated secretion of adrenal renin. Little data, however, are available for studying acute regulation of adrenal renin release.
We have recently generated a new monogenetic model of hypertension, the transgenic hypertensive rat TGR (mREN2 )27 (10) . The entire mouse Ren-2d renin gene is integrated into their genome and they are characterized by fulminant hypertension and suppressed plasma renin concentration, as well as high plasma prorenin levels and high tissue Ren-2d mRNA content. The highest expression of the transgene was found in the adrenal cortex, and the adrenal gland was demonstrated as a major source of plasma prorenin. Furthermore, adrenalectomy resulted in a dramatic drop in blood pressure in TGR(mREN2)27 (10, 11 Angiotensin II amide (Hypertensin) was purchased from Ciba (Zurich, Switzerland) and dissolved in 5 mM NaH2PO4. Final dilutions were done in the incubation medium. 8-bromo-cAMP (8-BrcAMP) and A23187 (Sigma, (Nos. B7880 and C7522, respectively; Sigma Chemical Co.) were dissolved in DMSO, and further diluted with the incubation medium.
Renin determinations. Plasma was collected as EDTA plasma, obtained from the retroorbital plexus after light ether anesthesia. Plasma active and inactive renin concentrations were determined according to a modification ofthe method described by Glorioso et al. (13) . In brief, to activate inactive renin 20 of plasma was incubated with 40 ,ul of trypsin (400 U/ml, dissolved in TES-buffer: 0.1 M TES, pH 7.2,0.01% neomycin, 10 mM EDTA). Samples were incubated on ice for 10 min, and the reaction was stopped by adding 40 Ml of soybean trypsin inhibitor (600 U/ml in TES-buffer). To determine inactive renin concentrations in adrenal homogenates and incubates, the concentrations of trypsin and soybean trypsin inhibitor were reduced to 50 U/ ml and 100 U/ ml, respectively. For the measurement of active renin, 80 Al of TES-buffer was added without trypsin.
The pretreated samples were incubated with lyophilized renin substrate isolated from nephrectomized rat plasma (final concentration: 80 mg/ml, 0.1 1% 2,3-dimercapto-1-propanol, 1.15 mg/ml 8-hydroxychinolin in TES-buffer). The reaction was stopped with RIA buffer (0.1 M Tris acetate, pH 7.4), (a) immediately before the incubation and (b) 1-3 h after incubation at 370C. Generated ANGI was measured by radioimmunoassay ( 14, 15 
Results
We recently demonstrated that the major site of Ren-2d gene expression in TGR(mREN2 )27 is the adrenal cortex ( 10, 17) . To examine the intraadrenal RAS, we addressed the question of whether adrenal renin activity is enhanced in TGR (mREN2 )27, due to the presence of mouse renin protein. Fig. 1 shows renin activity with and without trypsin activation in plasma, adrenal homogenates, and supernatants ofadrenal slice incubations. In plasma, the active renin level is significantly lower in TGR(mREN2)27 than in SD controls (Fig. 1  A; bar I vs. 3), while prorenin is elevated 20-fold in TGR(mREN2)27 (Fig. 1 D; column 1 vs. 3 ). In adrenal homogenates both active renin and prorenin are strongly elevated in TGR(mREN2)27 as compared with controls ( Fig. 1, B and E; bar I vs. 3).
Additionally, prorenin as well as active renin could be detected in the incubate of transgenic adrenal slices, indicating their release. Renin release from adrenal slices of SD rats was almost undetectable. To evaluate the contribution of mouse renin to determined renin activities, we measured the renin activities before and after immunoprecipitation with a monoclonal antibody capable of specifically recognizing mouse, but not rat, renin.
As shown in Fig. 1 , the immunoprecipitation with a mouse renin-specific antibody (No. 120) had no effect on the renin activities measured in SD rats (Fig. 1, A-F , bar I vs. 2), but significantly reduced renin activities in plasma, adrenal homogenates, and incubates of TGR(mREN2)27 (Fig. 1, A-F, bar 3 vs. 4). In TGR( mREN2 ) 27, renin activities in adrenal homogenates and incubates, as well as plasma prorenin, were almost completely blocked by the antibody to < 10% of the original values (Fig. 1, B-F, bar 3 vs. 4 ).
The plasma active renin level in transgenic rats was decreased by about two-thirds ( Fig. 1 A, bar 3 To examine the pattern of renin release from adrenal cells ofTGR(mREN2)27 in more detail and to study its regulation, we analyzed adrenal renin secretion in vitro. While the renin release from adrenal cell suspensions of SD rats (Table I) and also Wistar Kyoto rats (data not shown) was below the detection limit, adrenal cells ofTGR(mREN2 )27 secreted considerable amounts of active renin and prorenin (Table I) . Most of the intracellular content of prorenin was released into the me- To demonstrate the local synthesis of renin in adrenal cells of TGR(mREN2)27 we next examined the effect of translation inhibition by cycloheximide. As shown in Fig. 2 B, cycloheximide significantly inhibits the release ofprorenin to 20% of that of untreated cells and the release of active renin to 65% (Fig. 2 A) . The release of renin was not affected by cycloheximide during the first 90 min of incubation. In addition, it was more effective in inhibiting prorenin release than active renin release.
Using this system of adrenal cell suspensions in vitro, we were able to study the regulation of renin release from adrenal cells of TGR(mREN2)27. As shown in Fig. 3 A, the release of active renin was significantly stimulated by 8-Br-cAMP for 16 h compared with unstimulated transgenic adrenal cells. The prorenin release was significantly elevated by 8-Br-cAMP even after 6 h of stimulation (Fig. 3 B) . This was accompanied by a significant rise in Ren-2d mRNA as detected by a Ren2d-specific RNAse protection assay (Fig. 3 C) . Thus, the release of active renin~and prorenin from transgenic adrenal cells is stimulated by 8-Br-cAMP. This is in part due to enhanced de novo synthesis, as we conclude from the parallel increases of prorenin and Ren-2d mRNA under the same conditions.
We also focused on the major component of the negative feedback loop controlling renin release from the kidney, angiotensin II. Our ingly, as shown in Fig. 4 for renin activity after short incubation periods. The overexpression of transgenic renin in adrenal glands of TGR (mREN2)27, offers the opportunity to study those phenomena in TGR(mREN2)27. The above findings suggest the existence of a regulated secretory pathway for active renin release in adrenal cells ofTGR (mREN2) 27 . Therefore, we next examined the acute effects of 8-Br-cAMP, ANGII, and the calcium ionophore A23187.
As demonstrated in Fig. 5 , A-C, active renin release is significantly stimulated by all three drugs within 60 min of incubation (5 mM 8-Br-cAMP: 166±20%, P < 0.05; 1 nM ANGII:
118+±0%, P > 0.05; 10 nM ANGII: 162+20%, P < 0.05; 100 nM ANGII: 155±10%, P < 0.05; 1 pM A23187: 173±12%, P < 0.05). The effect of ANGII was dose dependent, reaching maximal stimulation with 10 nM ANGII. In the same experiments prorenin release was not significantly affected.
Discussion
Transgenic rats TGR(mREN2)27, having integrated the mouse Ren-2d renin gene, develop fulminant hypertension with systolic blood pressure ranging from 200 to 280 mmHg. We consider TGR(mREN2)27 as a model of "low plasma renin hypertension." We further hypothesize that the overexpression ofthe renin gene in certain tissues results in stimulated paracrine RAS, like in the brain, the blood vessels, the adrenal gland, or the heart. This may then lead to hypertension development in TGR( mREN2)27 and also to the observed downregulation of kidney renin. The existence of autocrine or paracrine RAS is supported by a number of recent findings (1, 4, 5) . Several lines of evidence indicate that hypertension in TGR(mREN2)27 is indeed determined by the transgene activity and is not a result of insertional mutagenesis. First, in sevAdrenal Renin in TGR (mREN2) 27 745 [25] [26] [27] .
The mechanisms of renin regulation and secretion in the adrenal gland remain far from being clear. Mizuno et al. (9) isolated renin-containing secretory granules from the rat adrenal cortex and demonstrated that their number is increased by nephrectomy, a maneuver that is known to increase the adrenal renin content. They, and Yamaguchi et al. (28) , also suggested a stimulatory long-term effect of ANGII on renin secretion from rat adrenal cortical primary cell cultures. However, due to the low abundance of renin in the rat adrenal cortex, the analysis of short-term regulation is limited.
The adrenal gland was shown to be a major source of plasma prorenin in TGR(mREN2)27, whereas the kidney renin production is strongly suppressed ( 10, 1 1) . The detection of high amounts of renin secreted from transgenic adrenal cells confirms this finding. We therefore asked whether or not adrenal renin is under regulatory control similar to kidney renin. 8-Br-cAMP, which is known to stimulate renin release from the kidney, also stimulates renin release from primary cells of TGR(mREN2)27 adrenal glands. ANGII and increased intracellular free calcium are well-known inhibitors of renal renin release and are important in negative feedback regulations of blood pressure ( 1) . Both factors do not suppress adrenal renin release in TGR( mREN2 )27 but instead significantly stimulate active renin release eliciting a quick response. Since ANGII is known to elevate intracellular free calcium, the effect ofANGII may be mediated via calcium.
The stimulatory effect of ANGII on active renin release may be an epiphenomenon of the transgenic model but could also represent an endogeneous mechanism. The findings of Mizuno et al. and Yamaguchi et al. (9, 28) speak in favor ofthe second possibility. Most likely, the specific apparatus ofthe cell type (e.g., endocrine cells, juxtaglomerular cells, submandibular gland cells) define in part the pattern of renin regulation. In any case, the positive feedback loop between renin release and ANGII may be important for the regulation of adrenal steroid metabolism, plasma renin, and in the pathophysiology of hypertension, at least in TGR(mREN2)27. This remains to be investigated.
